Tag: officer

 ABO-101 is an investigational gene editing therapy designed to address the underlying disease biology of PH1 by reducing hepatic oxalate production

MONTREAL and MCLEAN, Va., June 25, 2026 (GLOBE NEWSWIRE) -- NorthStar Earth & Space Inc. (“NorthStar” or the “Company”), a global leader in Space Situational Awareness (“SSA”) and Space Domain Awareness (“SDA”), and Viking Acquisition Corp. I (“Viking”) (NYSE: VACI), a special purpose acquisition company, announced today the public filing of their joint registration statement on Form F-4 (the “Registration Statement”) with the U.S. Securities and Exchange Commission (the “SEC”) in connection with their proposed business combination (the “Business Combination Agreement”) announced on April 17, 2026, available here.

Stewart Bain, Founder and Chief Executive Officer of NorthStar, said, “The public filing of our registration statement represents an important milestone in the process of becoming a public company. The market demand for NorthStar’s differentiated space-based intelligence platform requires accelerating our long-term growth strategy. Increased access to capital and global awareness, inherent with a public company, will enable us to expand capabilities and deepen customer support by delivering more critical insights to stakeholders through our services.”

Latest Supply & Trading Agreement Represents Significant Progress Toward Company's Long-Term Objective of $1 Billion in Annualized Commercial Activity